Related Experiment Videos
Hepatitis C virus infection in children
M Ruiz-Moreno1, A Leal-Orozco, A Millàn
1Pediatrics Department - Fundacion Jiménez Diaz, Universidad Autonoma de Madrid, Spain. rmoreno@fjd.es
Journal of Hepatology
|January 6, 2000
Summary
Hepatitis C virus (HCV) infection in children is mostly acquired vertically, with a 5% transmission risk. Chronic HCV in children presents with milder symptoms but requires long-term follow-up and further treatment studies.
Area of Science:
- Pediatric Infectious Diseases
- Hepatology
- Virology
Background:
- Hepatitis C virus (HCV) infection is uncommon in children, with blood transfusions historically being the primary transmission route.
- Vertical (perinatal) transmission of HCV is increasingly recognized as a significant mode of acquisition in pediatric populations.
- Maternal HIV co-infection and high viral load increase the risk of vertical HCV transmission.
Purpose of the Study:
- To summarize the current understanding of hepatitis C virus infection in children.
- To review the epidemiology, transmission, diagnosis, natural history, and treatment of pediatric HCV.
- To highlight the need for further research in pediatric HCV management.
Main Methods:
- Review of existing literature on pediatric hepatitis C virus infection.
- Analysis of diagnostic criteria for perinatal HCV transmission.
- Evaluation of the natural history and treatment outcomes in children with HCV.
Main Results:
- Vertical transmission accounts for a significant proportion of childhood HCV cases, with an overall risk of approximately 5%.
- Diagnosis requires HCV-RNA detection, as maternal antibodies can persist up to 18 months.
- Chronic HCV in children typically exhibits lower ALT levels and viral loads, with milder liver histology compared to adults.
- Treatment with interferon shows a sustained response in about 40% of pediatric cases.
Conclusions:
- Vertical transmission is a key route for pediatric HCV, necessitating accurate diagnostic approaches.
- The natural history of HCV in children is characterized by slower progression but chronicity remains common.
- Limited treatment data underscores the need for long-term follow-up and multicenter studies to optimize anti-viral therapy efficacy in childhood.